Charles Schwab Investment Management Inc Y M Abs Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 250,225 shares of YMAB stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250,225

Previous 247,506 1.1%

Holding current value

$3.02 Million

Previous $1.69 Million 141.14%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$6.57 - $18.69 $17,863 - $50,818	2,719 Added 1.1%	250,225 $4.07 Million
Q4 2023 Feb 06, 2024	SELL	$4.88 - $7.42 $9,457 - $14,379	-1,938 Reduced 0.78%	247,506 $1.69 Million
Q3 2023 Nov 08, 2023	SELL	$4.86 - $7.23 $37,183 - $55,316	-7,651 Reduced 2.98%	249,444 $1.36 Million
Q2 2023 Aug 09, 2023	BUY	$5.68 - $10.34 $121,864 - $221,844	21,455 Added 9.1%	257,095 $1.75 Million
Q1 2023 May 11, 2023	SELL	$2.83 - $5.11 $45,050 - $81,346	-15,919 Reduced 6.33%	235,640 $1.18 Million

Q4 2022 Feb 13, 2023	BUY	$3.0 - $15.17 $9,432 - $47,694	3,144 Added 1.27%	251,559 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $11,265 - $15,873	807 Added 0.33%	248,415 $3.58 Million
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $113,863 - $209,580	13,852 Added 5.93%	247,608 $3.75 Million
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $71,971 - $191,410	-10,988 Reduced 4.49%	233,756 $2.78 Million
Q4 2021 Feb 11, 2022	BUY	$15.51 - $29.31 $79,488 - $150,213	5,125 Added 2.14%	244,744 $3.97 Million
Q3 2021 Nov 16, 2021	BUY	$27.47 - $37.31 $1.03 Million - $1.4 Million	37,500 Added 18.55%	239,619 $6.84 Million
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $295,245 - $436,661	11,601 Added 6.09%	202,119 $6.83 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $380,304 - $677,662	13,042 Added 7.35%	190,518 $5.76 Million
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $198,234 - $284,105	5,236 Added 3.04%	177,476 $8.79 Million
Q3 2020 Nov 13, 2020	BUY	$35.13 - $43.62 $1.1 Million - $1.37 Million	31,359 Added 22.26%	172,240 $6.61 Million
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $474,927 - $994,215	20,073 Added 16.62%	140,881 $6.09 Million
Q1 2020 May 15, 2020	BUY	$14.39 - $35.8 $32,809 - $81,624	2,280 Added 1.92%	120,808 $3.15 Million
Q4 2019 Feb 07, 2020	BUY	$23.81 - $33.78 $747,014 - $1.06 Million	31,374 Added 36.0%	118,528 $3.7 Million
Q3 2019 Nov 08, 2019	BUY	$21.57 - $31.37 $456,270 - $663,569	21,153 Added 32.05%	87,154 $2.27 Million
Q2 2019 Aug 09, 2019	BUY	$19.51 - $28.31 $590,528 - $856,887	30,268 Added 84.71%	66,001 $1.51 Million
Q1 2019 May 14, 2019	SELL	$18.21 - $26.21 $30,028 - $43,220	-1,649 Reduced 4.41%	35,733 $937,000
Q4 2018 Feb 14, 2019	BUY	$15.41 - $28.92 $576,056 - $1.08 Million	37,382 New	37,382 $761,000

Others Institutions Holding YMAB

# of Institutions

Shares Held

22.4M

Call Options Held

37.4K

Put Options Held

48.2K

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $528M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Y M Abs Therapeutics, Inc. Transaction History